AUM$39.1M
Expense Ratio0.45%
NAV$58.89
Holdings—
InceptionNov 8, 2018
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
N/AAvg Volume
1.8KDividend Yield
—Expense Ratio
0.45%AUM
$39.1MShares Outstanding
—Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 95.12% |
| United Kingdom | 1.79% |
| Ireland | 1.40% |
| Switzerland | 1.08% |
| Netherlands | 0.61% |
Fund Information
- Issuer
- Global X
- Category
- Healthcare
- Inception Date
- Nov 8, 2018
- Description
- The Global X S&P Biotech ETF (CURE) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the S&P Biotechnology Select Industry Index.
Similar ETFs
The Global X - S&P Biotech ETF (CURE.AX) is an exchange-traded fund issued by Global X that launched on Nov 8, 2018. It currently manages $39.1M in assets under management. The fund charges an expense ratio of 0.45%. It falls under the Healthcare category.
Top 10 holdings represent 16.5% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | MRNA | MODERNA INC | 2.34% | 12,127 | $914K |
| 2 | ROIV | ROIVANT SCIENCES | 1.79% | 17,393 | $701K |
| 3 | ACLX | ARCELLX INC | 1.74% | 4,207 | $678K |
| 4 | PCVX | VAXCYTE INC | 1.64% | 8,095 | $642K |
| 5 | RVMD | REVOLUTION MEDIC | 1.55% | 4,520 | $606K |
| 6 | FOLD | AMICUS THERAPEUT | 1.55% | 29,839 | $605K |
| 7 | GILD | GILEAD SCIENCES | 1.51% | 2,901 | $591K |
| 8 | AMGN | AMGEN INC | 1.48% | 1,116 | $579K |
| 9 | PRAX | PRAXIS PRECISION | 1.48% | 1,346 | $576K |
| 10 | CGON | CG ONCOLOGY INC | 1.46% | 6,418 | $570K |
| 11 | MIRM | MIRUM PHARMACEUT | 1.43% | 4,414 | $559K |
| 12 | BMRN | BIOMARIN PHARMAC | 1.40% | 6,556 | $546K |
| 13 | UTHR | UNITED THERAPEUT | 1.40% | 726 | $546K |
| 14 | CELC | CELCUITY INC | 1.38% | 3,457 | $540K |
| 15 | VRTX | VERTEX PHARM | 1.37% | 792 | $534K |
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | — | — |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
—
Current Price
$60.75
52-Week Low
—
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | CURE.AX | Healthcare(223 ETFs) |
|---|---|---|
| Fund Info | ||
| Expense Ratio | 0.45% | 0.60% |
| AUM | $39.1M | $1.24B |
| Dividend Yield | — | 2.75% |
| Avg Volume | 1.8K | 800.9K |
| Holdings | — | 171 |
| Performance | ||
| 1-Month Return | — | -4.57% |
| 6-Month Return | — | +4.90% |
| YTD Return | — | -1.70% |
| 1-Year Return | — | +15.18% |
Compare with Another ETF
Search for an ETF to compare with CURE.AX: